|
1
|
International Agency for Research on
Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to
Humans. Human Papillomaviruses. 90. IARC Press; Lyon: 2007
|
|
2
|
Golas SM: Trends in palatine tonsillar
cancer incidence and mortality rates in the United States.
Community Dent Oral Epidemiol. 35:98–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Syrjänen S: HPV infections and tonsillar
carcinoma. J Clin Pathol. 57:449–455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Näsman A, Attner P, Hammarstedt L, Du J,
Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M,
Lindquist D, et al: Incidence of human papillomavirus (HPV)
positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of
viral-induced carcinoma? Int J Cancer. 125:362–366. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Näsman A, Nordfors C, Holzhauser S,
Vlastos A, Tertipis N, Hammar U, Hammarstedt-Nordenvall L, Marklund
L, Munck-Wikland E, Ramqvist T, et al: Incidence of human
papillomavirus positive tonsillar and base of tongue carcinoma: A
stabilisation of an epidemic of viral induced carcinoma? Eur J
Cancer. 51:55–61. 2015. View Article : Google Scholar
|
|
6
|
Gillison ML, Koch WM, Capone RB, Spafford
M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et
al: Evidence for a causal association between human papillomavirus
and a subset of head and neck cancers. J Natl Cancer Inst.
92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mellin H, Friesland S, Lewensohn R,
Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in
tonsillar cancer: Clinical correlates, risk of relapse, and
survival. Int J Cancer. 89:300–304. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dahlstrand HM and Dalianis T: Presence and
influence of human papillomaviruses (HPV) in tonsillar cancer. Adv
Cancer Res. 93:59–89. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lindquist D, Romanitan M, Hammarstedt L,
Näsman A, Dahlstrand H, Lindholm J, Onelöv L, Ramqvist T, Ye W,
Munck-Wikland E, et al: Human papillomavirus is a favourable
prognostic factor in tonsillar cancer and its oncogenic role is
supported by the expression of E6 and E7. Mol Oncol. 1:350–355.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pryor DI, Solomon B and Porceddu SV: The
emerging era of personalized therapy in squamous cell carcinoma of
the head and neck. Asia Pac J Clin Oncol. 7:236–251. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ramqvist T and Dalianis T: An epidemic of
oropharyngeal squamous cell carcinoma (OSCC) due to human
papilloma-virus (HPV) infection and aspects of treatment and
prevention. Anticancer Res. 31:1515–1519. 2011.PubMed/NCBI
|
|
12
|
Cancercentrum R: Nationellt vårdprogram
Huvud- och hals-cancer. 2015, In Swedish.
|
|
13
|
Näsman A, Andersson E, Nordfors C, Grün N,
Johansson H, Munck-Wikland E, Massucci G, Dalianis T and Ramqvist
T: MHC class I expression in HPV positive and negative tonsillar
squamous cell carcinoma in correlation to clinical outcome. Int J
Cancer. 132:72–81. 2013. View Article : Google Scholar
|
|
14
|
Näsman A, Andersson E, Marklund L,
Tertipis N, Hammarstedt-Nordenvall L, Attner P, Nyberg T, Masucci
GV, Munck-Wikland E, Ramqvist T, et al: HLA class I and II
expression in oropharyngeal squamous cell carcinoma in relation to
tumor HPV status and clinical outcome. PLoS One. 8:e770252013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Näsman A, Romanitan M, Nordfors C, Grün N,
Johansson H, Hammarstedt L, Marklund L, Munck-Wikland E, Dalianis T
and Ramqvist T: Tumor infiltrating CD8+ and
Foxp3+ lymphocytes correlate to clinical outcome and
human papillomavirus (HPV) status in tonsillar cancer. PLoS One.
7:e387112012. View Article : Google Scholar
|
|
16
|
Lindquist D, Ahrlund-Richter A, Tarján M,
Tot T and Dalianis T: Intense CD44 expression is a negative
prognostic factor in tonsillar and base of tongue cancer.
Anticancer Res. 32:153–161. 2012.PubMed/NCBI
|
|
17
|
Näsman A, Nordfors C, Grün N,
Munck-Wikland E, Ramqvist T, Marklund L, Lindquist D and Dalianis
T: Absent/weak CD44 intensity and positive human papillomavirus
(HPV) status in oropharyngeal squamous cell carcinoma indicates a
very high survival. Cancer Med. 2:507–518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nordfors C, Grün N, Tertipis N,
Ährlund-Richter A, Haeggblom L, Sivars L, Du J, Nyberg T, Marklund
L, Munck-Wikland E, et al: CD8+ and CD4+
tumour infiltrating lymphocytes in relation to human papillomavirus
status and clinical outcome in tonsillar and base of tongue
squamous cell carcinoma. Eur J Cancer. 49:2522–2530. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gooden MJ, de Bock GH, Leffers N, Daemen T
and Nijman HW: The prognostic influence of tumour-infiltrating
lymphocytes in cancer: A systematic review with meta-analysis. Br J
Cancer. 105:93–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sasagawa T, Takagi H and Makinoda S:
Immune responses against human papillomavirus (HPV) infection and
evasion of host defense in cervical cancer. J Infect Chemother.
18:807–815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Campo MS, Graham SV, Cortese MS, Ashrafi
GH, Araibi EH, Dornan ES, Miners K, Nunes C and Man S: HPV-16 E5
down-regulates expression of surface HLA class I and reduces
recognition by CD8 T cells. Virology. 407:137–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashrafi GH, Haghshenas MR, Marchetti B,
O'Brien PM and Campo MS: E5 protein of human papillomavirus type 16
selectively downregulates surface HLA class I. Int J Cancer.
113:276–283. 2005. View Article : Google Scholar
|
|
23
|
Li W, Deng XM, Wang CX, Zhang X, Zheng GX,
Zhang J and Feng JB: Down-regulation of HLA class I antigen in
human papillomavirus type 16 E7 expressing HaCaT cells: Correlate
with TAP-1 expression. Int J Gynecol Cancer. 20:227–232. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng XM, Li W, Zhang X, Wang CX, Dong ZG,
Zhang X, Zheng GX, Zhang XH, Zheng N, Wang LL, et al: RNA
interference of human papillomavirus type 16 E7 increases HLA class
I antigen expression in HaCaT-E7 cells. Int J Gynecol Cancer.
21:28–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spanos WC, Nowicki P, Lee DW, Hoover A,
Hostager B, Gupta A, Anderson ME and Lee JH: Immune response during
therapy with cisplatin or radiation for human
papillomavirus-related head and neck cancer. Arch Otolaryngol Head
Neck Surg. 135:1137–1146. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brenner JC, Graham MP, Kumar B, Saunders
LM, Kupfer R, Lyons RH, Bradford CR and Carey TE: Genotyping of 73
UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck.
32:417–426. 2010.
|
|
27
|
White JS, Weissfeld JL, Ragin CCR, Rossie
KM, Martin CL, Shuster M, Ishwad CS, Law JC, Myers EN, Johnson JT,
et al: The influence of clinical and demographic risk factors on
the establishment of head and neck squamous cell carcinoma cell
lines. Oral Oncol. 43:701–712. 2007. View Article : Google Scholar
|
|
28
|
Kiuru A, Servomaa K, Grénman R, Pulkkinen
J and Rytömaa T: p53 mutations in human head and neck cancer cell
lines. Acta Otolaryngol Suppl. 529(Suppl): 237–240. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramqvist T, Mints M, Tertipis N, Näsman A,
Romanitan M and Dalianis T: Studies on human papillomavirus (HPV)
16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue
cancer in relation to clinical outcome and immunological
parameters. Oral Oncol. 51:1126–1131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Villabona L, Leon Rodriguez DA, Andersson
EK, Seliger B, Dalianis T and Masucci GV: A novel approach for
HLA-A typing in formalin-fixed paraffin-embedded-derived DNA. Mod
Pathol. 27:1296–1305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reits EA, Hodge JW, Herberts CA, Groothuis
TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH,
Neijssen J, et al: Radiation modulates the peptide repertoire,
enhances MHC class I expression, and induces successful antitumor
immunotherapy. J Exp Med. 203:1259–1271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Griffin BD, Gram AM, Mulder A, Van Leeuwen
D, Claas FH, Wang F, Ressing ME and Wiertz E: EBV BILF1 evolved to
downregulate cell surface display of a wide range of HLA class I
molecules through their cytoplasmic tail. J Immunol. 190:1672–1684.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee BJ, Chon KM, Kim YS, An WG, Roh HJ,
Goh EK and Wang SG: Effects of cisplatin, 5-fluorouracil, and
radiation on cell cycle regulation and apoptosis in the
hypopharyngeal carcinoma cell line. Chemotherapy. 51:103–110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gupta AK, Lee JH, Wilke WW, Quon H, Smith
G, Maity A, Buatti JM and Spitz DR: Radiation response in two
HPV-infected head-and-neck cancer cell lines in comparison to a
non-HPV-infected cell line and relationship to signaling through
AKT. Int J Radiat Oncol Biol Phys. 74:928–933. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Maggio FM, Minafra L, Forte GI,
Cammarata FP, Lio D, Messa C, Gilardi MC and Bravatà V: Portrait of
inflammatory response to ionizing radiation treatment. J Inflamm
(Lond). 12:142015. View Article : Google Scholar
|
